Combination Therapy for Chronic Hepatitis C Infection

NCT01805882 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

229

Enrollment

NIH

Sponsor class

Conditions

Hepatitis C, Chronic

Interventions

DRUG: Sofosbuvir
DRUG: Ledipasvir
DRUG: GS-9669
DRUG: GS-9451

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)